Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Oncolytics Biotech's Fourth Quarter and Full Year 2023 Conference Call. All participants are now in a listen-only mode.
Oncolytics Biotech Inc (ONCY)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Anson Investments Amin Nathoo And Moez Kassam | 3,814,299 | $5,149,304 | -29% | 0.63% |
| 2. | Millennium Management Israel Englander | 127,842 | $172,589 | -40% | 0% |
| 3. | Citadel Investment Group Ken Griffin | 113,885 | $153,745 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 231,385 | $312,370 | 0% | |
| 2. | 199,777 | $269,699 | 0.03% | |
| 3. | 100,000 | $135,000 | 0.01% | |
| 4. | 54,925 | $74,000 | 0% | |
| 5. | 41,942 | $56,621 | 0% |
News See All
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Oncolytics Biotech's Third Quarter 2023 Conference Call. All participants are now in listen-only mode.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Oncolytics Biotech's Second Quarter 2023 Conference Call. All participants are now in listen-only mode.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2023 Earnings Call Transcript
Operator: Good morning. And welcome to Oncolytics Biotech's First Quarter 2023 Conference Call. All participants are now in listen-only mode.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2022 Earnings Call Transcript
Operator: Welcome to Oncolytics Biotech's Fourth Quarter and Full Year 2022 Conference Call. Please be advised that this call is being recorded at the company's request.
Is Oncolytics Biotech, Inc. (ONCY) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Progenics Pharmaceuticals, Inc. (PGNX): Insiders Aren't Crazy About It But Hedge Funds Love It
To the average investor, there are tons of indicators shareholders can use to watch publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading sentiment.
Hedge Funds Are Selling Threshold Pharmaceuticals, Inc. (THLD)
At the moment, there are tons of methods market participants can use to watch Mr. Market. A pair of the most useful are hedge fund and insider trading sentiment.
Is Coronado Biosciences Inc (CNDO) Going to Burn These Hedge Funds?
If you'd ask most market participants, hedge funds are viewed as worthless, old financial vehicles of years past.
Should You Avoid GTx, Inc. (GTXI)?
Is GTx, Inc. (NASDAQ:GTXI) a superb investment right now? Investors who are in the know are taking a pessimistic view.
Billionaire Hedge Funds
